CPA4 Promotes EMT in Pancreatic Cancer via Stimulating PI3K-AKT-mTOR Signaling

BACKGROUND: Carboxypeptidase A4 (CPA4), as a novel tumor biomarker, is prevalently observed in various cancers. However, the potential role of CPA4 in pancreatic cancer (PC), to our knowledge, has not been fully clarified. MATERIALS AND METHODS: We systematically explored the detailed function of CP...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Qingliang, Zhang, Zhiqiang, Cao, Rongxian, Zang, Hui, Pei, Wanting, Sun, Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457871/
https://www.ncbi.nlm.nih.gov/pubmed/32922037
http://dx.doi.org/10.2147/OTT.S257057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457871/
https://www.ncbi.nlm.nih.gov/pubmed/32922037
http://dx.doi.org/10.2147/OTT.S257057

Ejemplares similares